This inventor holds 13 USPTO granted patents and 4 published patent applications. Top assignees: Abbvie Biotechnology Ltd, Abbott Biotechnology Ltd., N.v. Organon. Active years: 2008-2021.
Company Filing History:
10 out of 93 
2 out of 17 
1 out of 101 
Years Active: 2008-2021
Title: Min M Wan: Innovator in Antibody Composition
Introduction
Min M Wan is a prominent inventor based in Worcester, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody compositions. With a total of 13 patents to his name, Wan has established himself as a key figure in his area of expertise.
Latest Patents
Among his latest innovations, Wan has developed a method for producing a host cell protein-(HCP) reduced antibody preparation. This invention involves an ion exchange separation step, wherein the mixture is subjected to a first ion exchange material, resulting in an HCP-reduced antibody preparation. This method enhances the purity and efficacy of antibody preparations, which is crucial for various therapeutic applications.
Career Highlights
Throughout his career, Min M Wan has worked with notable companies such as AbbVie Biotechnology Ltd and Abbott Biotechnology Ltd. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking advancements in biotechnology.
Collaborations
Wan has collaborated with esteemed colleagues, including George Avgerinos and Gregory Zarbis-Papastoitsis. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.
Conclusion
Min M Wan's contributions to the field of biotechnology, particularly in antibody composition, highlight his role as an influential inventor. His work continues to impact the industry, paving the way for future advancements in therapeutic applications.